当前位置:首页 - 行情中心 - 北大医药(000788) - 财务分析 - 现金流量表

北大医药

(000788)

  

流通市值:33.02亿  总市值:33.02亿
流通股本:5.96亿   总股本:5.96亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金451,230,437.122,098,209,170.911,517,794,528.27963,331,058.81
  收到的税费返还-3,022,725.02--
  收到其他与经营活动有关的现金5,554,402.1727,450,446.9823,848,600.0414,533,601.11
  经营活动现金流入小计456,784,839.292,128,682,342.911,541,643,128.31977,864,659.92
  购买商品、接受劳务支付的现金123,219,254.811,229,401,067.791,007,156,034.89661,150,444.27
  支付给职工以及为职工支付的现金61,105,952.06172,250,303.23133,109,214.6698,463,278.8
  支付的各项税费15,068,149.04111,821,00287,176,115.6962,763,089.84
  支付其他与经营活动有关的现金69,937,868.74227,918,412.6182,463,406.85132,380,131.72
  经营活动现金流出小计269,331,224.651,741,390,785.621,409,904,772.09954,756,944.63
  经营活动产生的现金流量净额187,453,614.64387,291,557.29131,738,356.2223,107,715.29
二、投资活动产生的现金流量:
  收回投资收到的现金90,524,102.8195,866,107.7653,153,941.04-
  取得投资收益收到的现金2,114,170.02-4,170,892.56-
  处置固定资产、无形资产和其他长期资产收回的现金净额162,480151,884.6466,897.3866,897.38
  收到的其他与投资活动有关的现金721.78---
  投资活动现金流入小计92,801,474.6196,017,992.457,391,730.9866,897.38
  购建固定资产、无形资产和其他长期资产支付的现金2,809,847.1848,766,517.8329,837,826.8720,244,544.91
  投资支付的现金134,084,842.68395,392,808.3977,961,305.59-
  投资活动现金流出小计136,894,689.86444,159,326.22107,799,132.4620,244,544.91
  投资活动产生的现金流量净额-44,093,215.25-348,141,333.82-50,407,401.48-20,177,647.53
三、筹资活动产生的现金流量:
  收到其他与筹资活动有关的现金-5,942,460.44--
  筹资活动现金流入平衡项目-0--
  筹资活动现金流入小计-5,942,460.44--
  偿还债务支付的现金-30,000,000--
  分配股利、利润或偿付利息支付的现金100,125,887.436,565,245.5130,383,546.1218,349,789.42
  支付其他与筹资活动有关的现金14,948,254.4519,819,417.7215,299,278.158,094,879.15
  筹资活动现金流出小计115,074,141.8586,384,663.2345,682,824.2726,444,668.57
  筹资活动产生的现金流量净额-115,074,141.85-80,442,202.79-45,682,824.27-26,444,668.57
五、现金及现金等价物净增加额28,286,257.54-41,291,979.3235,648,130.47-23,514,600.81
  加:期初现金及现金等价物余额545,138,690.34586,430,669.66586,430,669.66586,430,669.66
  期末现金及现金等价物余额573,424,947.88545,138,690.34622,078,800.13562,916,068.85
补充资料:
  净利润-82,882,957.79-100,293,909.16
  资产减值准备-26,449,796.67-1,438,819.07
  固定资产和投资性房地产折旧-16,077,156.31-7,994,388.85
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-16,077,156.31-7,994,388.85
  无形资产摊销-15,601,533.78-8,098,051.74
  长期待摊费用摊销-12,542.38--
  处置固定资产、无形资产和其他长期资产的损失--29,633.81-45,752.14
  固定资产报废损失--10,676.86--20,997.29
  财务费用-1,693,001.2-1,320,858.96
  投资损失--6,958,543.26--
  递延所得税--5,858,741.86-2,270,207.45
  其中:递延所得税资产减少--5,875,983.98-2,270,207.45
    递延所得税负债增加-17,242.12--
  存货的减少-49,694,012.2-22,119,952.79
  经营性应收项目的减少-533,937,051.37--69,020,105.87
  经营性应付项目的增加--348,960,905.14--61,928,195.83
  不涉及现金收支的投资和筹资活动金额其他项目-11,393,296.38--
  现金的期末余额-545,138,690.34-562,916,068.85
  减:现金的期初余额-586,430,669.66-586,430,669.66
  现金及现金等价物的净增加额--41,291,979.32--23,514,600.81
公告日期2026-04-282026-04-282025-10-312025-08-22
审计意见(境内)标准无保留意见
TOP↑